ARCHIVES

FDA Approves New Indication For Anticoagulant Frangmin

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

UC Davis Cancer Center Wins NCI Designation

July 19, 2002

Siteman Wins Core Grant; Other Cancer Center News.

August 31, 2001

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992